Tag Archives: U.S.

U.S. government gives Moderna Inc $472 million for coronavirus vaccine development

A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. (Photo by Maddie Meyer/Getty Images) Moderna Inc., a biotech company that develops pharmaceuticals, received $ 472 million award from the federal Biomedical Advanced Research and… Read More »

The Median Hospital Charge In the U.S. for COVID-19 Care Ranges From $34-45K

The median charge for hospitalizing a patient with COVID-19 ranged from $ 34,662 for people 23 to 30, and $ 45,683 for people between 51 and 60 years of age, according to FAIR Health’s research brief, Key Characteristics of COVID-19 Patients published July 14th, 2020. FAIR Health based these numbers on private insurance claims associated with… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Using his own ‘metrics,’ Trump says ending U.S. shutdown is biggest decision yet

WASHINGTON (Reuters) – President Donald Trump said on Friday he faced his biggest decision yet with regard to when to re-open the U.S. economy from its coronavirus shutdown and pledged to listen to health experts when making that determination. Speaking at a White House coronavirus briefing, Trump said he would unveil a new advisory group… Read More »